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أمناط وصفات األدوية اليت يصفها األطباء النفسانيون يف العيادات اخلارجية 
اخلاصة يف حمافظة كرمان بإيران
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abstract: Objectives: The aim of this study was to assess the pattern and utilisation of psychotropic  drug 
prescriptions by psychiatrists in Kerman Province, Iran. Methods: The prescriptions of 27 psychiatrists were 
randomly selected from two Iranian public insurance organisations and were analysed for the mean number of 
drugs/prescriptions, drug category and the most frequently prescribed drug in each category as well as overall. 
Results: A total of 6,414 prescriptions were analysed. The mean number of drugs per prescription was 2.9. 
Antidepressants (61.0%) were the most frequently prescribed category of psychotropic medications, followed 
by antipsychotics (29.5%), sedative/hypnotics or anti-anxiety drugs (27.5%) and mood stabilisers (18.5%). The 
combination of antidepressants with antipsychotics was the most commonly prescribed combination (18.8%). 
Fluoxetine (16.5%) and trifluoperazine (13.5%) were among the most frequently prescribed antidepressants and 
antipsychotics, respectively. Clonazepam (10.5%) was the most commonly prescribed benzodiazepine agent, 
followed by alprazolam (8.5%). In terms of total drug utilisation, sertraline (12.4%) was the most commonly used 
psychotropic medication followed by fluoxetine (9.7%), trifluoperazine (6.6%), propranolol (4.5%) and clonazepam 
(3.7%). Conclusion: A high proportion of psychotropic prescriptions in Kerman Province were for antidepressants, 
followed by antipsychotics and the benzodiazepines. Further research is needed to determine the underlying 
correlation between prescription practice and the diagnosis and patient characteristics, as well as to investigate the 
use of different psychotropic medications.
Keywords: Prescriptions, trends; Prescriptions, utilization; Psychotropic Drugs; Psychiatrists; Iran.
امللخ�ص: الهدف: تهدف هذه الدرا�سة لتقييم اأمناط و�سفات الأدوية التي ي�سفها الأطباء النف�سانيون يف عيادات الطب النف�سي اخلارجية 
اإيرانيتني  منظمتني  نف�سيا يف حمافظة كرميان من  27 طبيبا  و�سفات  ع�سوائيا  اأختريت  الطرق:  باإيران.  اخلا�سة يف حمافظة كرميان 
للتاأمني العام، ومت حتليلها للح�سول على متو�سط عدد الأدوية وت�سنيف الأدوية املو�سوفة، واأكرث الأدوية التي مت و�سفها يف كل �سنف. 
2.9 دواء. ووجد من درا�سة مناذج الأدوية املو�سوفة  6,414 و�سفة، وكان متو�سط عدد الأدوية يف كل و�سفة هو  النتائج: مت حتليل 
اأن %61.0 من تلك الأدوية كانت من م�سادات الكتئاب، تلتها م�سادات الذهان )بن�سبة %29.5( ثم املهدئات/املنومات/م�سادات 
القلق )بن�سبة %27.5( ثم مثبتات املزاج )%18.5(. وكانت اأكرث الأدوية التي اأعطيت معا هي م�سادات الكتئاب مع م�سادات القلق 
 .)13.5% )بن�سبة  الذهان تراي فلو بريازين  %16.5( مع م�ساد  )بن�سبة  الإكتئاب فلوك�سوتني  اأعطي م�ساد  %18.8(، حيث  )بن�سبة 
وكان اأكرث الأدوية التي و�سفت يف جمموعة البنزودايزبني هو كلونازبيام )بن�سبة %10.5(، تليه الربازولم )بن�سبة %8.5(. وبالن�سبة 
اإىل كل اأ�سناف الأدوية كان �سريتالين هو اأكرث دواء مت و�سفه )بن�سبة %12.4( وتاله فلوك�ستني )بن�سبة %9.7( ثم برارانالول )بن�سبة 
اأعلى ن�سب و�سفات الأدوية النف�سية يف  كانت  اخلال�صة:   .)6.6% )بن�سبة  %3.7( ثم تراي فلو بريازين  )بن�سبة  وكلونازيبام   )4.5%
حمافظة كرمان باإيران هي مل�سادات الكتئاب وتالها م�سادات الذهان وجمموعة بينزي دايزبني. ويجب يف الدرا�سات القادمة حتديد 
العالقة الكامنة بني ممار�سة كتابات الو�سفات الطبية والت�سخي�س وخ�سائ�س املري�س، ودرا�سة ا�ستخدام خمتلف الأدوية امل�ستخدمة يف 
الطب النف�سي.
مفتاح الكلمات: و�سفات طبية؛ توجهات؛ ا�ستخدام الأدوية؛ الأدوية النف�سية؛ الأطباء النف�سانيون؛ اإيران. 
Patterns of Psychotropic Medication  
Prescriptions by Psychiatrists for Private Clinic 
Outpatients in Kerman Province, Iran
Abdolreza Sabahi,1 *Gholamreza Sepehri,1 Mottahareh Mohsenbeigi,2 Ehsan Sepehri3
CLINICAL & BASIC RESEARCH
Sultan Qaboos University Med J, August 2014, Vol. 14, Iss. 3, pp. e382-387, Epub. 24TH Jul 14
Submitted 1ST Feb 14
Revision Req. 24TH Mar 14; Revision Recd. 26TH Mar 14 
Accepted 17TH Apr 14
1Neuroscience Research Center, Kerman University of Medical Sciences, Kerman, Iran; 2Kerman Social Security Organization, Kerman, Iran; 3Tehran 
University of Medical Sciences, Tehran, Iran
*Corresponding Author e-mail: gsepehri@yahoo.com 
Advances in Knowledge
- Antidepressant drugs are the group of psychotropic drugs most frequently prescribed by psychiatrists in Kerman Province, Iran, followed 
by antipsychotics and sedative/hypnotics.
- Fluoxetine, sertraline, propranolol and clonazepam are among the most frequently prescribed psychotropic drugs by this group of 
psychiatrists.
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An increasing trend in the prescription of psychotropic medications by physicians has been noted in recent years and the increase 
in psychotropic prescriptions by psychiatrists and 
general practitioners (GPs) has been reported in both 
developing and developed countries.1–4 Psychotropic 
medications are often prescribed for non-psychotic 
disorders, such as eating disorders in children, 
adolescents and adults.5 There is also an increased 
prevalence of antipsychotic drug use among children 
and adolescents, as well as an increasing trend in the 
abuse of central nervous system (CNS) stimulants 
among young adolescents, including amphetamines, 
methylphenidate and ecstasy. This has been observed in 
many countries, including Iran.6–9 There is a significant 
difference in the rate of prescription and consumption 
of sedative/hypnotic drugs and antidepressants 
between developed and developing countries. Anti-
anxiety drugs were the most frequently prescribed 
psychotropic drugs in various psychiatric disorders 
followed by antipsychotic drugs and antidepressant 
drugs in outpatients (OPD) of a psychiatry department 
in India;10 however, stimulants and antidepressants 
consistently ranked first and second in psychotropic 
medication treatment for youths in USA.11
Only a few studies have examined prescribing 
practices among physicians in Kerman Province, Iran. 
One study reported prescription practices among GPs, 
reported that sedative/hypnotic drugs were prescribed 
for 19.56% of patients visited by GPs.12 Another study 
among residents living in Bam, a city in Iran, observed 
that drugs affecting the CNS were the most frequently 
prescribed, representing 52.7% of all prescribed 
drugs.13
To date there has been no reliable information on 
the prescribing habits of psychiatrists in Iran; thus, this 
study aimed to assess the pattern of drug prescription 
and utilisation of psychotropic medications in 
outpatients visited by psychiatrists at private clinics in 
Kerman Province, Iran.
Methods
This retrospective cross-sectional study was 
conducted over a one-year period between 1st 
May 2012 and 1st May 2013. The prescriptions of 
27 psychiatrists were randomly selected from two 
Iranian public insurance organisations in Kerman 
Province. The Iranian Social Security Organization 
(SSO) provides legally compulsory insurance coverage 
to workers and employees in the private sector. Self-
employed individuals can also elect to belong to 
the SSO (n = 4,391). The Iranian Medical Services 
Insurance Organization (MSIO) covers a wide range of 
individuals in the community, including government 
employees and individuals of various socioeconomic 
levels who are not eligible to be covered by other 
insurance organisations (n = 2,023). A total of 6,414 
prescriptions were randomly selected from these two 
public insurance companies and analysed, with at least 
100 prescriptions per psychiatrist.
Prescriptions that had been issued to patients of 
all ages and both genders and which contained at least 
one psychotropic medication were included in the 
study. Drug-related information (including the drug 
names, dose, dosage form and route of administration) 
were recorded on a customised data collection sheet. 
Anaesthetics, antiepileptic medications and drugs 
used in the management of Parkinsonism were 
excluded from the study.
The data were also analysed using three World 
Health Organization (WHO) indicators to determine 
drug use in a health facility: the average number 
of drugs per encounter, the percentage of drugs 
prescribed under a generic name and the percentage 
of injections prescribed per encounter.14 The drug 
categories and the most frequently prescribed drugs 
Table 1: Drug use indicators for psychiatrist-prescribed 
psychotropic prescriptions for outpatients in Kerman 
Province, Iran*
Indicators n %
Average number of drugs per prescription 2.9 -
Number of drugs prescribed by generic 
name
5,452 85
Prescriptions with complete documentation† 6,029 94
Number of drug injections prescribed 257 4
*Using the World Health Organization indicators to determine drug 
use in a health facility.14   †Including complete drug name, dose, dosage 
form and route of administration.
Application to Patient Care
- The high rate of antidepressant prescriptions found in this study is of special importance. Further research should be carried out to 
determine whether these drugs are prescribed for outpatients with depression or if they are used to treat patients with diagnoses other 
than depressive disorders.
- In addition, it is recommended that health organisations investigate the reasons for the high rate of psychotropic prescriptions in Kerman 
Province and implement interventional programmes to improve the rational prescription of these medications through standardised 
treatment guidelines. 
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in each category were also recorded. Drug utilisation 
was measured by taking the total defined daily doses 
for each drug or drug category and dividing this 
by the total defined daily doses of all psychotropic 
medications.
The psychotropic drugs were classified into 
six therapeutic drug classes: antipsychotics, 
antidepressants; sedative/hypnotics (anti-anxiety); 
CNS stimulants; mood stabilisers (lithium, sodium 
valproate or carbamazepine) and others (beta blockers, 
antihistamines, anticholinergic agents, etc.).
The data were processed and presented using the 
Statistical Package for the Social Sciences (SPSS), 
Version 13 (IBM, Corp., Chicago, Illinois, USA). The 
Mann-Whitney U nonparametric test was used to 
compare the differences between the utilisation of 
each drug group. Approval to use the data was granted 
by both the SSO and the MSIO.
Results
A total of 6,414 psychiatric outpatient prescriptions 
were analysed using the WHO indicators to determine 
drug use in a health facility.14 Overall, the mean number 
of drugs per prescription was 2.9 (range: 1–12). 
The majority of prescriptions (94%) had complete 
documentation regarding the drug information. 
Most of the drugs (85%) were prescribed by a generic 
name. Injectable drugs were prescribed in 4% of the 
prescriptions (range: 1–15%) [Table 1].
A total of 52 different drugs were prescribed 
to outpatients of which 32 drugs were from the 
psychotropic category. The most frequently prescribed 
psychotropic medications were antidepressants 
(61.0%), followed by antipsychotics (29.5%), sedative/
hypnotic/anti-anxiety drugs (27.5%) and mood 
stabilisers (18.5%) [Table 2].
In the antidepressant drug category, fluoxetine 
(16.5%) was the most commonly prescribed 
antidepressant, followed by sertraline (15.0%). 
Trifluoperazine (13.5%) was the preferred drug within 
the antipsychotics group, followed by quetiapine 
(4.5%). Clonazepam (10.5%) was the most commonly 
prescribed benzodiazepine agent among the sedative/
hypnotics category, followed by alprazolam (8.5%).
Among the mood stabilisers, lithium (12.3%) 
was preferred over sodium valproate (4.8%) and 
Table 3: Utilisation patterns of the most common 
psychiatrist-prescribed psychotropic drugs for 











Fluoxetine (C) 16.5 9.7 10




Propranolol (FcT) 11.5 4.5 10
Clonazepam (ST) 10.5 3.7 2
Alprazolam (ST) 8.5 1.4 0.5
Citalopram (T) 6.5 3.1 30




Olanzapine (T) 3.0 0.6 5
C = capsule; T = tablet; ScT= sugar-coated tablet; FcT= film-coated 
tablet; ST = scored tablet.
Table 2: Prescription patterns of the most common 
psychiatrist-prescribed psychotropic drugs by selected 
drug categories for outpatients in Kerman Province, 
Iran





Antidepressants 3,912 (61.0) 38.2
Fluoxetine 1,058 (16.5) 9.7
Sertraline 962 (15.0) 12.4
Citalopram 417 (6.5) 3.2
Others 1,475 (23.0) 12.9
Antipsychotics 1,892 (29.5) 17.5
Trifluoperazine 866 (13.5) 6.6
Quetiapine 289 (4.5) 2.4
Olanzapine 192 (3.0) 1.6
Others 545 (8.5) 6.9
Sedative/hypnotics 1,764 (27.5) 17.5
Clonazepam  674 (10.5) 3.7
Alprazolam 545 (8.5) 3.2
Chlordiazepoxide 224 (3.5) 2.8
Others 321 (5.0) 7.8
Mood stabilisers 1,187 (18.5) 8.6
Lithium 789 (12.3) 6.0
Sodium valproate 308 (4.8) 2.1
Carbamazepine 90 (1.4) 0.5
Stimulants 481 (7.5) 4.8
Methylphenidate 481 (7.5) 4.8
Other CNS drugs 923 (14.4) 11.4
CNS = central nervous system. *More than one drug may have been 
prescribed per patient.
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carbamazepine (1.4%). Methylphenidate was the most 
commonly prescribed stimulant (7.5%) [Table 2]. 
Utilisation patterns of the most commonly 
prescribed drugs were measured by taking the total 
defined daily doses for each drug or drug category 
and dividing this by the total defined daily doses of 
all psychotropic medications. In terms of total drug 
utilisation, antidepressants were the most commonly 
prescribed psychotropic medications (38.2%), followed 
by antipsychotics (17.5%) and sedative/hypnotics 
(17.5%). In all drug categories, sertraline (12.4%) was 
the most commonly used psychotropic medication 
followed by fluoxetine (9.7%), propranolol (4.5%) and 
clonazepam (3.7%) [Table 3]. The results of the current 
study showed that drug utilisation patterns in Kerman 
Province are in accordance with the prescription 
pattern.
Table 4 shows the types of psychotropic drug 
combinations prescribed to outpatients by the 
psychiatrists. Antidepressants and antipsychotics were 
the most commonly prescribed combination (18.8%), 
followed by the triple combination of antidepressants, 
antipsychotics and sedative/hypnotics (12.6%).
Discussion
Since the prescription pattern of Iranian psychiatrists 
has not been reported previously, to the best of the 
authors’ knowledge, this study is a preliminary report 
for psychotropic medications in Iran. On average, 
a mean of 2.9 drugs were prescribed to outpatients 
per prescription. This is significantly higher than 
reported in similar studies in both developing and 
developed countries, such as Thailand and the 
USA, respectively.3,15 However, the findings of this 
study are comparable with a similar report from 
India.16 The majority of drugs were prescribed by 
their generic names. The rate of prescriptions that 
were accompanied by complete documentation and 
the percentage of injectable drugs prescribed were 
comparable to a similar study by Udomratn et al.17
The results of this study showed that psychiatrists 
prescribed antidepressants most frequently. The 
psychiatrists’ antidepressant prescription rate was 
significantly higher than the reported values for 
a similar study (23.1–48.6%).18 Antidepressants 
paired with antipsychotics were the most commonly 
prescribed combination (18.8%), which is comparable 
to findings from the study by Udomratn et al.17 In the 
USA, Goodwin et al. reported that stimulants were the 
most commonly prescribed drug category, followed by 
antidepressants, anxiolytics, antipsychotics and mood 
stabilisers.19 Psychotropic medication consumption 
patterns in a study of the general population in the 
UK was dominated by hypnotics, antidepressants and 
anxiolytics.20
The reasons behind this high rate of antidepressant 
prescription are of special importance; the diagnosis by 
which antidepressant drugs are prescribed should be 
clarified. Specifically, it is important to know whether 
antidepressant drugs are prescribed for  depression 
or for patients with diagnoses other than depressive 
disorders, such as anxiety disorders, eating disorders, 
enuresis, urinary stress incontinence or personality 
disorders.10,21 The high rate of antidepressant 
prescriptions found in the current study suggests a 
need for continued investigation and a systematic 
analysis of the specific disorders that are being treated 
with antidepressants. An increase in psychotropic 
and antidepressant prescriptions and their utilisation 
has been reported from other parts of the world 
as well.11,22 von Soest et al. reported a relationship 
between socioeconomic status and antidepressant 
prescriptions.23
The results of the present study showed that 
the most frequently prescribed antidepressants in 
Kerman Province were fluoxetine and sertraline, 
which accounted for 57% of all prescriptions; this 
finding is comparable to some previous studies in 
which selective serotonin reuptake inhibitors (SSRIs) 
were the preferred prescribed antidepressant class of 
drugs.24,25 Fluoxetine, paroxetine and sertraline were 
the most frequently prescribed antidepressants in a 
Spanish study, accounting for 58% of all prescriptions 
in depressed patients.24 The tolerability and efficacy 
of SSRIs in comparison with tricyclic antidepressants 
(TCAs) is controversial; however, some investigators 
have reported that SSRIs show an advantage in terms 
of tolerability in contrast to most TCAs.25,26
The current study’s results showed that 
antipsychotics were the second most frequently 
prescribed drug category by psychiatrists, which is 
not comparable to the results of similar studies in 
other parts of the world.19,20 Goodwin et al. reported 
Table 4: Psychiatrist-prescribed psychotropic drug 
category combinations for outpatients in Kerman 
Province, Iran
Drug category combination Prescription 
rate  
n (%)
Antidepressants and antipsychotics 1,206 (18.8)




sedative/hypnotics and mood 
stabilisers
353 (5.5)
Other combinations 1,379 (21.5)
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that stimulants were the most commonly prescribed 
psychotropic medications to youths in office-based 
practice in the USA followed by antidepressants, 
anxiolytics, antipsychotics and mood stabilisers;19 
however, hypnotics were the most commonly 
prescribed psychotropic medications in the UK 
general population followed by antidepressants 
and anxiolytics.20 In an Indian outpatient setting, 
antipsychotics were the second most commonly 
prescribed psychotropic drugs.10 A marked variation 
in antipsychotic and sedative/hypnotic prescriptions 
by psychiatrists and an increase in typical and 
atypical antipsychotic drug use has been reported in 
both developed and developing countries.7,27 These 
variations could be due to economic and social factors, 
drug availability, knowledge of adverse drug reactions 
and differences in morbidity.22
In the present study, trifluoperazine was the 
preferred antipsychotic followed by quetiapine 
and olanzapine. The results were comparable to 
those of Xiang et al., who found that quetiapine and 
olanzapine, second-generation antipsychotics, were 
the drugs most commonly prescribed to treat older 
schizophrenic patients in Asia between 2001–2009.28
The results of the present study showed that 
27.5% of patients were prescribed a benzodiazepine 
agent, which is higher than rates reported in some 
developing and developed countries.29,30  However, a 
higher benzodiazepine prescription rate (82.83%) by 
psychiatrists was reported in a study of outpatients 
in India.16 Benzodiazepines are efficacious for a wide 
range of conditions such as anxiety, insomnia, tonic-
clonic seizures and muscular spasms; however, their 
rational use requires an understanding of the variable 
differences in potency, efficacy and duration of action 
between different benzodiazepines.31
In the current study, lithium was the preferred 
mood stabiliser and was prescribed over sodium 
valproate and carbamazepine—this finding is in 
harmony with another study from Asia.32 However, 
other researchers have reported that sodium 
valproate was the most frequently prescribed drug 
for manic-depressive patients.33 The appropriateness 
of prescribing psychotropic medications as mood 
stabilisers needs further research.
Methylphenidate was the only psychiatrist-
prescribed stimulant for the treatment of attention 
deficit disorder in children, which is comparable to the 
reports of other investigators.34,35 However, the rate of 
methylphenidate misuse or abuse was not determined 
in the current study and requires further investigation.
Fluoxetine, sertraline, trifluoperazine and 
clonazepam were among the most commonly 
prescribed psychotropic medications, which is 
in agreement with a previous report.24 However, 
propranolol was also among the most frequently 
prescribed drugs, which is one of the noteworthy 
findings of this study. Propranolol is mainly prescribed 
by psychiatrists to relieve the somatic manifestations 
of general and performance anxiety.
The reasons underlying the overall high rate of 
psychotropic medication prescription found in this 
study should be investigated. It is hoped that this type 
of research may provide a greater understanding of the 
prescribing patterns observed in the current study.
The study has several limitations which should be 
clarified. This survey is the result of the prescription 
patterns of 27 psychiatrists in Kerman Province in Iran; 
this population does not represent all psychiatrists 
throughout Iran (approximately 400). In addition, the 
information recorded on the prescriptions analysed 
did not include the patient’s age, main diagnosis or 
socioeconomic status; these are significant factors 
affecting prescription patterns.23 A larger survey 
is recommended to evaluate Iranian psychiatrists’ 
psychotropic medication prescription patterns with 
an emphasis on the relationship between prescription 
pattern and patient diagnosis.
Conclusion
In summary, this is the first study to investigate 
prescription practices among psychiatrists in Iran. The 
results showed that the most common prescriptions 
were for antidepressants, followed by antipsychotics 
and benzodiazepines (sedative/hypnotics). The high 
rate of antidepressant prescriptions is of special 
importance. Future studies are  recommended to 
investigate whether antipressant drugs are prescribed 
solely for depressive disorders or if they are used 
to treat patients with other diagnoses. Further 
research is also needed to investigate a possible link 
between prescription practices, diagnoses, patient 
characteristics and the prescription of different 
antidepressants.
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